Skip to main content

Hannah Valantine, Professor of Medicine at Stanford University, is nationally recognized for her pioneering work in developing and applying paradigm-shifting genomic tools for the diagnosis of organ transplant rejection. She has also pursued a data-driven transformative approach to diversity equity and inclusion, receiving the NIH Director’s Pathfinder Award for this work, serving as the inaugural NIH Chief Officer for Scientific Workforce diversity, and as a tenured investigator at the National Heart, Lung, and Blood Institute where she established the Laboratory of Transplantation Genomics. Dr Valantine was elected to the National Academy of Medicine in 2020.

Leave a Reply